A/Professor Sanjay Patel is a Staff Interventional Cardiologist and Director of the Cardiac Catheterisation Laboratories, Royal Prince Alfred Hospital; Group Leader at the Heart Research Institute and Clinical Associate Professor at the Sydney Medical School.
He was awarded his MBBS (Hons 1) from the University of Sydney in 2000; completed his advanced Cardiology training at Royal Prince Alfred Hospital in 2006; and his doctoral studies in 2009, supported by a NHF postgraduate research scholarship. He then undertook postdoctoral studies at Stanford University, whilst simultaneously training in interventional cardiology at Stanford University Medical Centre (2009-2010), supported by an NHMRC CJ Martin Overseas Fellowship Grant.
A/Professor Patel has specific expertise in complex coronary intervention, intra-coronary imaging, renal artery denervation and transcatheter structural procedures (including PFO/ASD closure, balloon mitral valvuloplasty, prosthetic perileak closure). He also established a CT coronary angiography co-reporting service at RPAH and Alfred Imaging and currently holds level A CT certification.
As a cardiovascular researcher, he has published over 100 research papers and abstracts; and leads a translational coronary disease program at RPAH and HRI, with a specific focus on drug therapies targeting arterial inflammation. This program has attracted over $1millon in peer-reviewed research funding.
Management of complex coronary artery disease, including complex disorders of cholesterol metabolism and reversing atherosclerosis.
Radial approach coronary intervention, as well as interventions for structural heart disease, peripheral vascular disease and renal artery denervation.
Patel S, Kiefer TL, Ahmed A, Tremmel JA, Lee, DP, Yeung AC, Fearon WF. Coronary Artery Disease is Less Frequent with Alcohol-Related Compared to Non-Alcohol-Related Endstage Liver Disease. American Journal of Cardiology, 2011. In Press
Patel S, Di Bartolo B, Nakhla S, Heather AK, Mitchell TW, Jessup W, Celermajer DS, Barter PJ, KA Rye. Anti-Inflammatory Effects of ApoA-I in the Rabbit. 2010. Atherosclerosis. 2010;212: 392-7
Patel S, Chung SH, White G, Bao S, Celermajer DS. The "Atheroprotective" Mediators ApolipoproteinA-I and Foxp3 are Over-abundant in Unstable Carotid Plaques. International Journal of Cardiology. 2010;145: 183-7
Patel S, Drew BG, Nahkla S, Duffy SJ, Barter PJ, Rye K-A, Dusting J-C, Hoang A, Murphy A, Sviridov, D, Celermajer DS, Kingwell BA. Reconstituted HDL Increases Plasma HDL Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients with Type 2 Diabetes. Journal of the American College of Cardiology. 2009;53: 962-71
Patel S, Puranik R, Nakhla S, Lundman P, Stocker R, Wang XS, Lambert G, Rye K-A, Barter PJ, Nicholls SJ, Celermajer DS. Acute Hypertriglyceridaemia in Humans Increases the Triglyceride Content and Decreases the Anti- Inflammatory Capacity of High Density Lipoproteins. Atherosclerosis. 2009;204: 424-428
Patel S, Lee, D. On and Off: The Dilemma of Managing STEMI After Hours. The Journal of Invasive Cardiology. 2009;21: 523-524
Patel S, Adams MR. Prevention of cardiac disease - life style modification or pharmacotherapy?" Internal Medicine Journal. 2008;38: 199-203
Patel S, Celermajer, DS, Bao, S. Atherosclerosis - underlying inflammatory mechanisms and clinical implications. The International Journal of Biochemistry and Cell Biology. 2008;40: 576-580
Patel S. High Density Lipoproteins – The Next Frontier in Lipid Management. The Medical Journal of Australia. 2008;189: 421-422